Genotype directed therapy in murine mismatch repair deficient tumors.
The PI3K/AKT/mTOR pathway has frequently been found activated in human tumors. We show that in addition to Wnt signaling dysfunction, the PI3K/AKT/mTOR pathway is often upregulated in mouse Msh2(-/-) initiated intestinal tumors. NVP-BEZ235 is a dual PI3K/mTOR inhibitor toxic to many cancer cell line...
Main Authors: | Melanie H Kucherlapati, Shadi Esfahani, Peiman Habibollahi, Junning Wang, Eric R Still, Roderick T Bronson, Umar Mahmood, Raju S Kucherlapati |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3720855?pdf=render |
Similar Items
-
Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression.
by: Peng-Chieh Chen, et al.
Published: (2008-06-01) -
Genetic mechanisms in Apc-mediated mammary tumorigenesis.
by: Mari Kuraguchi, et al.
Published: (2009-02-01) -
Mouse models in colon cancer, inferences, and implications
by: Melanie Haas Kucherlapati
Published: (2023-06-01) -
Constitutional mismatch repair-deficiency syndrome
by: Katharina Wimmer, et al.
Published: (2010-05-01) -
Mismatch Repair Deficiency and Microsatellite Instability
by: Sandra Schöniger, et al.
Published: (2022-08-01)